ArticleCADTH technology overviews2012

Clopidogrel compared with other antiplatelet agents for secondary prevention of vascular events in adults undergoing percutaneous coronary intervention: clinical and cost-effectiveness analyses.

Sy Chen et al.PubMed ↗Full text ↗

No numbers read from the abstract.